Eli Lilly is working on a new GLP-1 drug, and early results suggest it could be a big winner.

REGIONS NEWS Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 ...

Doctronic reports that Foundayo, an oral GLP-1 for diabetes, shows promise but lacks long-term safety data beyond 68 weeks; ...

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for ...

The survey was conducted by the Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London.

Prospective, multicenter trial will evaluate a novel preservation technique utilizing the SherpaPak ® for DCD (Donation afterCirculatoryDeath) hearts.

The synovial sarcoma clinical trial analysis report delivers important insights into ongoing research of 20+ pipeline ...

Advocate Health partners clinical trial matching by integrating Lind's AI platform into its EHR to improve cancer patient eligibility screening.

AINMF READ THE FULL AINMF RESEARCH REPORT AINMF believes platform is well-positioned, as use of AI in clinical development is expected to rise NetraMark (OTCQB: AINMF), an AI company developing AI and ...

Prospective, multicenter trial will evaluate a novel preservation technique utilizing the Paragonix SherpaPak ® for DCD (Donation after ...

Trogenix’s proprietary dual-payload AAV gene therapyTGX-007 leverages Trogenix’s precision synthetic super-enhancer platform that selectively activates therapeutic immune payloads within tumour cells ...